BE663693A - - Google Patents

Info

Publication number
BE663693A
BE663693A BE663693DA BE663693A BE 663693 A BE663693 A BE 663693A BE 663693D A BE663693D A BE 663693DA BE 663693 A BE663693 A BE 663693A
Authority
BE
Belgium
Prior art keywords
radical
alkyl
substituted
free
sep
Prior art date
Application number
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of BE663693A publication Critical patent/BE663693A/fr
Priority claimed from NL6504085A external-priority patent/NL6504085A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BE663693D 1965-03-31 BE663693A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6504085A NL6504085A (pt) 1962-07-04 1965-03-31

Publications (1)

Publication Number Publication Date
BE663693A true BE663693A (pt)

Family

ID=19792803

Family Applications (1)

Application Number Title Priority Date Filing Date
BE663693D BE663693A (pt) 1965-03-31

Country Status (2)

Country Link
BE (1) BE663693A (pt)
NL (1) NL123139C (pt)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
EP2060575A1 (de) 2006-04-19 2009-05-20 Boehringer Ingelheim International GmbH Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
EP2380891A1 (de) 2007-10-19 2011-10-26 Boehringer Ingelheim International Gmbh Substituierte Piperidino-Dihydrothienopyrimidine
WO2014124860A1 (en) 2013-02-14 2014-08-21 Boehringer Ingelheim International Gmbh Specific pde4b-inhibitors for the treatment of diabetes mellitus

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
EP2060575A1 (de) 2006-04-19 2009-05-20 Boehringer Ingelheim International GmbH Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
EP2380891A1 (de) 2007-10-19 2011-10-26 Boehringer Ingelheim International Gmbh Substituierte Piperidino-Dihydrothienopyrimidine
EP2610258A1 (de) 2007-10-19 2013-07-03 Boehringer Ingelheim International Gmbh Substituierte Piperidino-Dihydrothienopyrimidine
WO2014124860A1 (en) 2013-02-14 2014-08-21 Boehringer Ingelheim International Gmbh Specific pde4b-inhibitors for the treatment of diabetes mellitus

Also Published As

Publication number Publication date
NL123139C (pt)

Similar Documents

Publication Publication Date Title
RU2208010C2 (ru) Фармацевтическая композиция (варианты), производные 3,5-дифенил-1,2,4-триазолов, в нее входящие
RU2683566C1 (ru) Производное с сочлененными кольцами и способ его получения, промежуточное соединение, фармацевтическая композиция и их применение
DE69827786T2 (de) Condensierte pyridazine derivate,deren herstellung und verwendung
EP0042593A1 (de) Aryloxypropanolamine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
JPS626703B2 (pt)
TW200530251A (en) Compositions useful as inhibitors of protein kinases
JPH08500841A (ja) キナゾリン誘導体
US20220259222A1 (en) Mk2 inhibitors, the synthesis thereof, and intermediates thereto
Shukla et al. Synthesis, characterization and in vitro biological evaluation of a series of 1, 2, 4-triazoles derivatives & triazole based schiff bases
EP0053767B1 (de) Tricyclische Cytosinderivate zur Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung
CA2368815A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
US20070105837A1 (en) Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2][2]-benzazepine, method for the production thereof and use thereof in the production of medicaments
BE663693A (pt)
JPH0586067A (ja) 光学活性なチエノトリアゾロジアゼピン化合物
FR2522000A1 (fr) Nouvelles thiopyrannopyrimidines, utiles notamment comme agents hypoglycemiants, et leur fabrication
US3487083A (en) Preparation of 4-hydroxypyrazolo(3,4-d)pyrimidine
US4146713A (en) Method of preparing 3-morpholino-2-cyanoacrylamide
US4343801A (en) 1,2,4-Triazine derivatives, and their production and use
RU1776261C (ru) Способ получени производных триазолопиримидина или их смеси, или их фармацевтически приемлемых солей с металлами
AT391695B (de) Neue verbindungen, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
JPS6121948B2 (pt)
JPS5970669A (ja) 〔２−〔（ニトロピリジニル）アミノ〕フエニル〕アリ−ルメタノン、その用途及び製造方法
KR800000854B1 (ko) 나프티리딘 유도체의 제법
US2803627A (en) Therapeutic quinoline compounds
BE525394A (pt)